Get started
RocketTickers

FDA Approves Myriad’s myChoice® CDx Test to Help Identify Women

Long
Myriad Genetics, Inc. (NASDAQ:MYGN)  
RocketTickers  
NASDAQ:MYGN   Myriad Genetics, Inc.
Beyond Technical Analysis
4
1
beyondta
MYGN: Myriad Genetics, Inc.
2019-10-23 17:40:52
FDA Approves Myriad’s myChoice® CDx Test to Help Identify Women Eligible for Treatment with Zejula® in Late-line Ovarian Cancer
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.